acute lymphoblastic leukemia造句
1. Second neoplasms after acute lymphoblastic leukemia in childhood.
2. Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia.
3. Hereditary and acquired p53 mutations in childhood acute lymphoblastic leukemia.
4. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
5. Central nervous system treatment in childhood acute lymphoblastic leukemia: long-term follow-up of patients diagnosed between 1973 and 1985.
6. Second malignancies in patients treated for childhood acute lymphoblastic leukemia.
7. Objective To predict the prognosis of children acute lymphoblastic leukemia (ALL) by using glucocorticosteroid induction test.
8. Objective To study the cross-lineage expression of acute lymphoblastic leukemia(ALL) with the use of multi-parameter flow cytometry in the immunophenotype of ALL.
9. In children with acute lymphoblastic leukemia,[http://] there is some evidence to suggest that girls are more likely to have long-term cognitive problems than boys.
10. Acute lymphocytic leukemia is also known as acute lymphoblastic leukemia and acute childhood leukemia.
11. L-asparaginase(L-ASP) is a very effective therapeutic drug in acute lymphoblastic leukemia for both adult and pediatric patients and included in nearly every ALL protocol.
12. Objective: To discuss the immunophenotype characteristics of acute lymphoblastic leukemia with myeloid antigen expression and relative analysis.
13. We describe an 11-year-old boy with ureteropelvic obstruction secondary to pancreatitis following chemotherapy for acute lymphoblastic leukemia.
14. Objective It is to study the characteristic of immunophenotype in adult acute lymphoblastic leukemia(B-ALL) and its clinic meaning in detecting minimal residual diseases(MRD).
15. Objective To study the molecular biological features in the elderly with acute lymphoblastic leukemia.
16. Objective To explore the clinical significance of quantitative analysis of minimal residual disease (MRD) cells DNA in children with acute lymphoblastic leukemia (ALL).
17. The objective of this study was to investigate the immunophenotypic characteristics of Tcell acute lymphoblastic leukemia.
18. Objective To improve the clinical significance of detecting minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL).
19. Objective: To predict the effect of Glucostricosteroid(GC) on the prognosis of children acute lymphoblastic leukemia(ALL) by using Dexamethasone induction test.
20. Objective To study the frequency and clinical significance of transloation, ets, leukemia-acute myeloblasticleukemia1 (TEL-AML1) fusion gene in children with acute lymphoblastic leukemia (ALL).
21. Objective:To investigate the diagnostic value of single photon emission computed tomography(SPECT) in early Daunorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia.
22. Objective To analyze the chromosomal changes and its clinical significance in childhood acute lymphoblastic leukemia(ALL).
23. L-asparaginase is regarded as an effective anti-cancer drug used for the treatment of acute lymphoblastic leukemia and malignant lymphosarcoma.
24. Objective To communicate the experience of unrelated-donor peripheral blood stem cell transplantation(URD-PBSCT) for acute lymphoblastic leukemia(ALL) patient with multiple high disk factors.
25. Objective To illuminate the expression of stem cell leukemia(SCL) gene in acute lymphoblastic leukemia(ALL) and clinical implications.
26. L- asparaginase is a very effective anti - tumor agent, it is a widely used agent against childhood acute lymphoblastic leukemia (ALL).
27. l-asparaginase is a very effective anti - tumor agent, it is a widely used agent against childhood acute lymphoblastic leukemia (ALL).
28. Objective To investigate the significance of serial monitoring of minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL).
29. OBJECTIVE: Minimal residual disease is one of the most important prognostic factors in childhood acute lymphoblastic leukemia.
30. Objective To establish a HPLC method to measure thioguanine nucleotides concentration in children with acute lymphoblastic leukemia.
12